Angiotensiinikonvertaasi 2 (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Angiotensiinikonvertaasi 2" in Finnish language version.

refsWebsite

Global rank Finnish rank

4^th place

12^th place

2^nd place

10^th place

5^th place

9^th place

doi.org

ND Rawlings et al: Handbook of proteolytic enzymes, s. 499–501. (3. painos) Academic press, 2012. doi:10.1016/C2009-1-60990-4 ISBN 9780123822192
JL Guy et al: Membrane-associated zinc peptidase families: comparing ACE and ACE2. Biochimica et Biophysica Acta. Proteins and Proteomics, 2005, 1751. vsk, nro 1, s. 2–8. PubMed:16054014 doi:10.1016/j.bbapap.2004.10.010 ISSN 1570-9639 Artikkelin verkkoversio.
M Li et al: Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty, 2020, 9. vsk, nro 1, s. 45. PubMed:32345362 doi:10.1186/s40249-020-00662-x ISSN 2049-9957 Artikkelin verkkoversio.
J Wysocki et al: Targeting the degradation of angiotensin II with recombinant ACE2: prevention of angiotensin II-dependent hypertension. Hypertension, 2010, 55. vsk, nro 1, s. 90–98. PubMed:19948988 doi:10.1161/HYPERTENSIONAHA.109.138420 ISSN 0194-911X Artikkelin verkkoversio.
P Verdecchia et al: The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine, 2020, nro 76, s. 14–20. PubMed:32336612 doi:10.1016/j.ejim.2020.04.037 ISSN 0953-6205 Artikkelin verkkoversio.

C Schindler et al: Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy. Vascular Health and Risk Management, 2007, 3. vsk, nro 1, s. 125–137. PubMed:17583183 ISSN 1176-6344 Artikkelin verkkoversio.
JL Guy et al: Membrane-associated zinc peptidase families: comparing ACE and ACE2. Biochimica et Biophysica Acta. Proteins and Proteomics, 2005, 1751. vsk, nro 1, s. 2–8. PubMed:16054014 doi:10.1016/j.bbapap.2004.10.010 ISSN 1570-9639 Artikkelin verkkoversio.
M Li et al: Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty, 2020, 9. vsk, nro 1, s. 45. PubMed:32345362 doi:10.1186/s40249-020-00662-x ISSN 2049-9957 Artikkelin verkkoversio.
J Wysocki et al: Targeting the degradation of angiotensin II with recombinant ACE2: prevention of angiotensin II-dependent hypertension. Hypertension, 2010, 55. vsk, nro 1, s. 90–98. PubMed:19948988 doi:10.1161/HYPERTENSIONAHA.109.138420 ISSN 0194-911X Artikkelin verkkoversio.
P Verdecchia et al: The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine, 2020, nro 76, s. 14–20. PubMed:32336612 doi:10.1016/j.ejim.2020.04.037 ISSN 0953-6205 Artikkelin verkkoversio.

C Schindler et al: Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy. Vascular Health and Risk Management, 2007, 3. vsk, nro 1, s. 125–137. PubMed:17583183 ISSN 1176-6344 Artikkelin verkkoversio.
JL Guy et al: Membrane-associated zinc peptidase families: comparing ACE and ACE2. Biochimica et Biophysica Acta. Proteins and Proteomics, 2005, 1751. vsk, nro 1, s. 2–8. PubMed:16054014 doi:10.1016/j.bbapap.2004.10.010 ISSN 1570-9639 Artikkelin verkkoversio.
M Li et al: Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty, 2020, 9. vsk, nro 1, s. 45. PubMed:32345362 doi:10.1186/s40249-020-00662-x ISSN 2049-9957 Artikkelin verkkoversio.
J Wysocki et al: Targeting the degradation of angiotensin II with recombinant ACE2: prevention of angiotensin II-dependent hypertension. Hypertension, 2010, 55. vsk, nro 1, s. 90–98. PubMed:19948988 doi:10.1161/HYPERTENSIONAHA.109.138420 ISSN 0194-911X Artikkelin verkkoversio.
P Verdecchia et al: The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine, 2020, nro 76, s. 14–20. PubMed:32336612 doi:10.1016/j.ejim.2020.04.037 ISSN 0953-6205 Artikkelin verkkoversio.

C Schindler et al: Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy. Vascular Health and Risk Management, 2007, 3. vsk, nro 1, s. 125–137. PubMed:17583183 ISSN 1176-6344 Artikkelin verkkoversio.
JL Guy et al: Membrane-associated zinc peptidase families: comparing ACE and ACE2. Biochimica et Biophysica Acta. Proteins and Proteomics, 2005, 1751. vsk, nro 1, s. 2–8. PubMed:16054014 doi:10.1016/j.bbapap.2004.10.010 ISSN 1570-9639 Artikkelin verkkoversio.
M Li et al: Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty, 2020, 9. vsk, nro 1, s. 45. PubMed:32345362 doi:10.1186/s40249-020-00662-x ISSN 2049-9957 Artikkelin verkkoversio.
J Wysocki et al: Targeting the degradation of angiotensin II with recombinant ACE2: prevention of angiotensin II-dependent hypertension. Hypertension, 2010, 55. vsk, nro 1, s. 90–98. PubMed:19948988 doi:10.1161/HYPERTENSIONAHA.109.138420 ISSN 0194-911X Artikkelin verkkoversio.
P Verdecchia et al: The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine, 2020, nro 76, s. 14–20. PubMed:32336612 doi:10.1016/j.ejim.2020.04.037 ISSN 0953-6205 Artikkelin verkkoversio.